BidaskClub Upgrades Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (AVDL) to Hold

BidaskClub upgraded shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) from a sell rating to a hold rating in a research report released on Wednesday, January 10th.

Several other analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a hold rating to a sell rating in a research note on Tuesday, January 9th. Roth Capital set a $14.00 price target on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share and gave the company a buy rating in a research note on Wednesday, January 3rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of $21.50.

Shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ AVDL) traded down $0.32 during midday trading on Wednesday, reaching $9.60. 496,292 shares of the company traded hands, compared to its average volume of 257,296. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share has a one year low of $7.52 and a one year high of $12.30. The stock has a market cap of $397.63, a PE ratio of 4.97 and a beta of 1.31. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.47 and a current ratio of 1.53.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) last announced its quarterly earnings data on Wednesday, November 8th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.13. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share had a net margin of 44.47% and a return on equity of 33.92%. The company had revenue of $39.68 million during the quarter, compared to analysts’ expectations of $38.22 million. During the same quarter in the prior year, the company earned ($0.08) EPS. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share’s revenue was up 23.7% compared to the same quarter last year. research analysts anticipate that Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share will post 0.32 earnings per share for the current fiscal year.

In related news, CEO Michael S. Anderson acquired 5,000 shares of the firm’s stock in a transaction dated Thursday, December 7th. The shares were purchased at an average cost of $8.86 per share, for a total transaction of $44,300.00. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Craig R. Stapleton sold 254,265 shares of the stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,377,377.75. Following the sale, the director now owns 253,413 shares in the company, valued at $2,369,411.55. The disclosure for this sale can be found here. Corporate insiders own 5.07% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the business. Stifel Financial Corp lifted its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 4.3% during the 2nd quarter. Stifel Financial Corp now owns 60,500 shares of the company’s stock worth $667,000 after buying an additional 2,500 shares in the last quarter. Janney Montgomery Scott LLC acquired a new stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 3rd quarter worth approximately $2,100,000. Citadel Advisors LLC acquired a new stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 2nd quarter worth approximately $354,000. Virtu KCG Holdings LLC acquired a new stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 2nd quarter worth approximately $259,000. Finally, Stonepine Capital Management LLC lifted its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 31.7% during the 3rd quarter. Stonepine Capital Management LLC now owns 985,210 shares of the company’s stock worth $10,345,000 after buying an additional 237,347 shares in the last quarter. Institutional investors own 67.73% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/05/avadel-pharmaceuticals-plc-american-depositary-shares-each-representing-one-ordinary-share-avdl-upgraded-by-bidaskclub-to-hold.html.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share Company Profile

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to commercialize differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results.

Receive News & Ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply